Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates anti-tumor immune responses. Huang F, Goncalves C, Bartish M, Remy-Sarrazin J, et al. J Clin Invest 2021 Mar 9. pii: 140752. doi: 10.1172/JCI140752.

Read + Share

Amedeo Smart

Independent Medical Education

Huang F, Goncalves C, Bartish M, Remy-Sarrazin J, et al. Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates anti-tumor immune responses. J Clin Invest 2021 Mar 9. pii: 140752. doi: 10.1172/JCI140752.
PMID: 33690225